Stockholm - Delayed Quote SEK

Mentice AB (publ) (MNTC.ST)

16.35
-0.75
(-4.39%)
At close: May 9 at 5:18:19 PM GMT+2
Loading Chart for MNTC.ST
  • Previous Close 17.10
  • Open 16.90
  • Bid 16.05 x --
  • Ask 16.35 x --
  • Day's Range 15.80 - 17.05
  • 52 Week Range 15.80 - 40.00
  • Volume 159,322
  • Avg. Volume 10,741
  • Market Cap (intraday) 418.05M
  • Beta (5Y Monthly) 0.80
  • PE Ratio (TTM) --
  • EPS (TTM) -0.72
  • Earnings Date Jul 24, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 41.12

Mentice AB (publ) develops, sells, and markets solutions for training and decision support in the clinical area of interventional angiography in cardiology, neurology, vascular surgery, and radiology in Europe, the Middle East, Africa, Asia, the Asia Pacific region, and the Americas. It operates through the Mentice VIST, Physical Sim, and Ankyras segments. The company offers virtual simulation products, including VR simulator platforms; procedural learning models; patient simulator accessories and extensions for endovascular therapies; and Angiosuite integrations comprising the VIST virtual patient and Laerdal SimMan vascular medical simulator. It also provides flow model products, which include physiological flow systems, extensions and add-ons, silicone and 3D printed vessels, and flow system accessories; Ankyras, a clinical decision application; Mentice Live, a cloud-based learning center for medical technology industry and healthcare providers; Mentice Right Heart Cath app, a mobile solution for an interactive real-time exploration into the right heart catheterization procedure; Vascular Twin, an anatomical replication for procedural and device adoption; and research and development services. Mentice AB (publ) was founded in 1998 and is headquartered in Gothenburg, Sweden.

www.mentice.com

131

Full Time Employees

December 31

Fiscal Year Ends

Recent News: MNTC.ST

View More

Performance Overview: MNTC.ST

Trailing total returns as of 5/9/2025, which may include dividends or other distributions. Benchmark is OMX Stockholm 30 Index (^OMX) .

YTD Return

MNTC.ST
35.88%
OMX Stockholm 30 Index (^OMX)
1.38%

1-Year Return

MNTC.ST
45.68%
OMX Stockholm 30 Index (^OMX)
5.41%

3-Year Return

MNTC.ST
73.20%
OMX Stockholm 30 Index (^OMX)
27.89%

5-Year Return

MNTC.ST
66.63%
OMX Stockholm 30 Index (^OMX)
56.66%

Compare To: MNTC.ST

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: MNTC.ST

View More

Valuation Measures

Annual
As of 5/7/2025
  • Market Cap

    504.98M

  • Enterprise Value

    460.53M

  • Trailing P/E

    --

  • Forward P/E

    65.79

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.74

  • Price/Book (mrq)

    3.52

  • Enterprise Value/Revenue

    1.59

  • Enterprise Value/EBITDA

    25.17

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -6.31%

  • Return on Assets (ttm)

    -2.13%

  • Return on Equity (ttm)

    -12.17%

  • Revenue (ttm)

    291.81M

  • Net Income Avi to Common (ttm)

    -18.42M

  • Diluted EPS (ttm)

    -0.72

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    53.59M

  • Total Debt/Equity (mrq)

    6.36%

  • Levered Free Cash Flow (ttm)

    6.42M

Research Analysis: MNTC.ST

View More

Company Insights: MNTC.ST

Research Reports: MNTC.ST

View More

People Also Watch